Currently, several predictive factors, such as histological subtypes or biomarkers, including Ki-67 and epidermal growth factor receptor (EGFR), have shown important clinical value in the treatment and prognosis of NSCLC patients. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.